Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,357,932 papers from all fields of science
Search
Sign In
Create Free Account
ganglioside, GD2
Known as:
GD2 ganglioside
, GalNAc(beta 1->4)-[NeuAc(alpha 2->8)NeuAc(alpha 2->3)]Gal(beta 1->4)GlcCer
, Ganglioside GD2
A cell surface antigen expressed on all tumors of neuroectodermal origin, including melanoma, neuroblastomas, sarcoma, astrocytomas, and small cell…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (1)
Gangliosides
NCIt Antineoplastic Agent Terminology
dinutuximab
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Expression of Ganglioside GD2 on Colorectal Adenocarcinoma Cells
A. Lupatov
,
A. Gisina
,
+5 authors
R. Kholodenko
Biochemistry (Moscow), Supplement Series B…
2020
Corpus ID: 211726661
Abstract The expression of ganglioside GD2 on the cell lines of colorectal adenocarcinoma HT29 and CaCo-2, as well as on the…
Expand
2017
2017
Abstract P6-02-01: Metabolic stress induces GD2 expression and cancer stem cell phenotype in triple negative breast cancer
V. Battula
,
B. Piyaranthna
,
+5 authors
M. Andreeff
2017
Corpus ID: 79014141
Breast cancer stem cells (BCSCs) have been characterized as a fraction of cells in primary tumors that are drug resistant and…
Expand
2016
2016
Chitosan nanoparticles targeted to the tumor-associated ganglioside GD2
A. Zubareva
,
A. Boyko
,
+7 authors
R. Kholodenko
Russian journal of bioorganic chemistry
2016
Corpus ID: 254979342
Methodological approaches to the creation of nanoparticles based on chitosan derivatives and targeted to the GD2-positive tumor…
Expand
2015
2015
GD 2 ganglioside specific antibody treatment downregulates PI 3 K / Akt / mTOR signaling network in human neuroblastoma cell lines
Małgorzata Durbas
,
Irena Horwacik
,
Elżbieta Boratyn
,
E. Kamycka
,
H. Rokita
2015
Corpus ID: 30030789
Mechanisms leading to inhibitory effects of an anti-GD2 ganglioside (GD2) 14G2a mouse monoclonal antibody (mAb) and PI3K/Akt/mTOR…
Expand
2013
2013
Targeting GD 2 ganglioside and aurora A kinase as a dual strategy leading to cell death in cultures of human neuroblastoma cells
Irena Horwacik
,
Małgorzata Durbas
,
Paulina Węgrzyn
,
H. Rokita
2013
Corpus ID: 5709992
2012
2012
Microenvironment and Immunology Trifunctional Bispeci fi c Antibodies Induce Tumor-Speci fi c T Cells and Elicit a Vaccination Effect
N. Eissler
,
P. Ruf
,
J. Mysliwietz
,
H. Lindhofer
,
R. Mocikat
2012
Corpus ID: 1200360
A major goal of tumor immunotherapy is the induction of long-lasting systemic T-cell immunity. Bispecific antibodies (bsAbs) that…
Expand
2007
2007
Use of monoclonal antibodies specific to o-acetylated form of ganglioside gd2 for treating certain forms of cancer
Стефан Биркль
,
Жан-Мари Мюссини
,
Жак Обри
,
Жак Барбе
,
Жан-Франсуа Шаталь
2007
Corpus ID: 102920005
FIELD: medicine. SUBSTANCE: what is offered is the use of monoclonal antibodies recognising the O-acetylated form of ganglioside…
Expand
Review
2007
Review
2007
Binding Activities and Antitumor Properties of a NewMouse / Human Chimeric Antibody Specific for GD 2
Nidia Alvarez-Rueda
,
phanie Leprieur
,
+6 authors
phane Birkle
2007
Corpus ID: 2686486
Purpose:We previously generated a mouse monoclonal antibody (mAb) specific for the tumorassociated GD2 ganglioside antigen. Here…
Expand
2007
2007
Targeting GD2 ganglioside-expressing tumor cells with the mimetic peptide vaccine
A. Kowalczyk
2007
Corpus ID: 89057592
1981
1981
Immunochemical relationship between Forssman and globoside glycolipid antigens.
R. Karol
,
S. Kundu
,
D. Marcus
Immunological Communications
1981
Corpus ID: 22677190
The rabbit antibody response to the human blood group P glycolipid antigen, globoside, GalNAc(beta 1-3)Gal(alpha 1-4)Gal(beta 1-4…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE